RFA Clinical Trials

52 recruitingLast updated: June 18, 2026

There are 52 actively recruiting rfa clinical trials across 32 countries. Studies span Not Applicable, Phase 4, Early Phase 1, Phase 2, Phase 3. Top locations include Toulouse, France, Hangzhou, Zhejiang, China, Alliance, Ohio, United States. Updated daily from ClinicalTrials.gov.


RFA Trials at a Glance

52 actively recruiting trials for rfa are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 21 trials, with the heaviest enrollment activity in Toulouse, Hangzhou, and Alliance. Lead sponsors running rfa studies include IRCCS Policlinico S. Donato, University Hospital, Toulouse, and Andres Schanzer.

Browse rfa trials by phase

Treatments under study

About RFA Clinical Trials

Looking for clinical trials for RFA? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new RFA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about RFA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 52 trials

Recruiting

Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy

Inflammatory DiseaseRetinal DiseaseOcular Surface Disease+1 more
Dan Chen3,000 enrolled1 locationNCT07628946
Recruiting

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

Pancreatic LesionGastrointestinal LesionsMicrowave Ablation+2 more
West Virginia University50 enrolled1 locationNCT07625189
Recruiting

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Dry Eye Disease (DED)Diabetes Type 2Diabete Mellitus+3 more
Attikon Hospital100 enrolled1 locationNCT07605572
Recruiting
Not Applicable

The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease

Dry EyeDry Eye SyndromesOcular Surface Disease
Rinsada33 enrolled1 locationNCT07618364
Recruiting
Not Applicable

Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

Neonatal Brain Injuryperinatal morbidityMechanical Ventilation+10 more
Medical College of Wisconsin320 enrolled1 locationNCT07274527
Recruiting
Phase 4

Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes

Cerebral oxygen saturationInfant Respiratory Distress SyndromeCerebral Oxygenation+3 more
Medical University of Graz76 enrolled1 locationNCT07261787
Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Sudden Cardiac DeathArrhythmogenic Right Ventricular DysplasiaCardiomyopathy, Dilated+11 more
Hospital do Coracao1,211 enrolled27 locationsNCT06546137
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled42 locationsNCT02012699
Recruiting
Phase 4

Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome

SurfactantRespiratory Distress Syndrome in Premature InfantsRespiratory Distress Syndrome (RDS)
Uludag University234 enrolled5 locationsNCT07350018
Recruiting
Not Applicable

The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis

Ocular Surface DiseaseFacial Paralysis, PeripheralBell's Palsy
The First Affiliated Hospital of Zhejiang Chinese Medical University78 enrolled1 locationNCT07537426
Recruiting
Phase 4

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency

Ocular Surface DiseaseNeurotrophic Keratopathy Stage 1
University of South Florida50 enrolled1 locationNCT07502378
Recruiting
Early Phase 1

Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion

DeliriumPain, BackSpinal Fusion+1 more
University of Iowa50 enrolled1 locationNCT05461092
Recruiting
Phase 4

Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa

Premature BirthRespiratory Distress Syndrome in Premature InfantSurfactant Deficiency Syndrome Neonatal+1 more
Indiana University1,512 enrolled8 locationsNCT06554522
Recruiting
Not Applicable

Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa

HPVOcular Surface Squamous Neoplasia
AIDS Malignancy Consortium84 enrolled1 locationNCT04704648
Recruiting

Biological Collection for Marfan and Related Syndromes

Marfan Syndrome
University Hospital, Toulouse300 enrolled1 locationNCT04970459
Recruiting
Early Phase 1

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

Interstitial Lung DiseaseSurfactant Dysfunction
Children's Hospital of Fudan University60 enrolled1 locationNCT04532346
Recruiting

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

GlaucomaOcular Surface Disease
University of California, Los Angeles75 enrolled1 locationNCT04354545
Recruiting

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

Arteriovenous MalformationsVascular AnomalyOsler Rendu Disease+3 more
Hospices Civils de Lyon400 enrolled36 locationsNCT04194619
Recruiting
Not Applicable

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome

Marfan Syndrome
University Hospital, Toulouse30 enrolled1 locationNCT05838235
Recruiting

Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions

Emerging Infectious DiseasesCommunicable DiseasesBiological Warfare Agents+2 more
Assistance Publique - Hôpitaux de Paris800 enrolled10 locationsNCT07411729